Screening for Fabry Disease in Renal Transplantation (DEFYT)
Sponsor: University Hospital, Montpellier
Terminated
Low recreuitement numbers and end of grant.
Other terminated trials from University Hospital, Montpellier
Other Fabry Disease trials with similar outcome
A observational or N/A phase clinical study on Fabry Disease and Nephropathy, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Montpellier and has accumulated 12 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Jun 2025 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Feb 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jan 2023 — Sep 2023 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
May 2022 — Jan 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — May 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — Feb 2020 [monthly]
Not Yet Recruiting
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .